The genome sequence enabled the researchers to examine genes involved in the synthesis of ginsenosides, the bioactive component of ginseng.
While actual clinical implementation remains distant, MALDI imaging technology has advanced to the point where it might feasibly be applied to pathology.
Researchers at Pacific Northwest National Laboratory are among those pushing ion mobility spectrometry as a tool to boost complex biological sample analysis.
The two studies were part of larger project aimed at building a complete map of mitochondrial function and associated proteins.
A team of scientists has begun to unravel the mysterious mechanisms behind metastatic organotropism, which has been puzzling scientists for over a century.
The approach brings together the spatial resolution of optical microscope and the rich molecular information generated by imaging mass spectrometry.
Fluidigm said that its fourth quarter revenues increased 60 percent year over year or 21 percent on an organic basis.
VICAM, a business of Waters, this week introduced its new Myco6in1+ LC/MS/MS immunoaffinity column for detection of mycotoxins.
Buoyed by increased researcher interest and new vendor offerings, imaging mass spectrometry is approaching a "tipping point," Vanderbilt researcher Richard Caprioli told ProteoMonitor this week.
By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Nine German universities have won a total of €5.8 million ($8.2 million) from the government to buy imaging mass spectrometers for a range of life sciences research applications.
An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.
In Science this week: reduction in bee phylogenetic diversity, and more.
The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.
The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.